Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dendritic cell therapy in cancer treatment; the state-of-the-art
Mahsa Sadeghzadeh, Soghra Bornehdeli, Haniye Mohahammadrezakhani, et al.
Life Sciences (2020) Vol. 254, pp. 117580-117580
Closed Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

Self-Healing Injectable Hydrogels for Tissue Regeneration
Pascal Bertsch, Mani Diba, David Mooney, et al.
Chemical Reviews (2022) Vol. 123, Iss. 2, pp. 834-873
Open Access | Times Cited: 449
Engineered cellular immunotherapies in cancer and beyond
Amanda Finck, Tatiana Blanchard, Christopher P. Roselle, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 678-689
Open Access | Times Cited: 208
Necroptosis in Immuno-Oncology and Cancer Immunotherapy
Jenny Sprooten, Pieter De Wijngaert, Isaure Vanmeerbeek, et al.
Cells (2020) Vol. 9, Iss. 8, pp. 1823-1823
Open Access | Times Cited: 147
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
Raquel S. Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 93
Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma
Lingbo An, Mingyang Li, Qingge Jia
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 68
Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities
Mona Meng Wang, Sarah E. Coupland, Tero Aittokallio, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 8, pp. 1212-1224
Open Access | Times Cited: 45
Dendritic Cells in Cancer Immunology and Immunotherapy
Laura Hato, Ángel Vizcay Atienza, Iñaki Eguren, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 981-981
Open Access | Times Cited: 44
Biomaterials for in situ cell therapy
Chang Wang, Siyu Wang, Diana D. Kang, et al.
BMEMat (2023) Vol. 1, Iss. 3
Open Access | Times Cited: 43
Recent advances in regenerative medicine strategies for cancer treatment
Vahid Mansouri, Nima Beheshtizadeh, Maliheh Gharibshahian, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111875-111875
Open Access | Times Cited: 70
Immunotherapies for hepatocellular carcinoma
Justin K. H. Liu, Andrew F. Irvine, Rebecca Jones, et al.
Cancer Medicine (2021) Vol. 11, Iss. 3, pp. 571-591
Open Access | Times Cited: 63
Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells
Mu Qi, Masoud Najafi
International Immunopharmacology (2021) Vol. 98, pp. 107895-107895
Closed Access | Times Cited: 58
Dendritic cells a critical link to alveolar bone loss and systemic disease risk in periodontitis: Immunotherapeutic implications
Ahmed El‐Awady, Mahmoud Elashiry, Ana Carolina Morandini, et al.
Periodontology 2000 (2022) Vol. 89, Iss. 1, pp. 41-50
Open Access | Times Cited: 56
Nanocarriers: A Reliable Tool for the Delivery of Anticancer Drugs
Hussein Sabit, Mohamed Abdel-Hakeem, Tahsin Shoala, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1566-1566
Open Access | Times Cited: 55
The ambiguous role of obesity in oncology by promoting cancer but boosting antitumor immunotherapy
José Antônio Fagundes Assumpção, Gabriel Pasquarelli-do-Nascimento, Mariana Saldanha Viegas Duarte, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 50
Autoimmunity and Cancer—Two Sides of the Same Coin
Justyna Sakowska, Łukasz Arcimowicz, Martyna Jankowiak, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 39
Dysfunction of dendritic cells in tumor microenvironment and immunotherapy
Jie Chen, Yu-Hang Duan, Junye Che, et al.
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 1047-1070
Open Access | Times Cited: 10
Nucleic Acid-Based Approaches for Tumor Therapy
Simone Hager, Frederic Julien Fittler, Ernst Wagner, et al.
Cells (2020) Vol. 9, Iss. 9, pp. 2061-2061
Open Access | Times Cited: 56
Identification and quantification of immune infiltration landscape on therapy and prognosis in left- and right-sided colon cancer
Junnan Guo, Du Chen, Shen-Hui Deng, et al.
Cancer Immunology Immunotherapy (2021) Vol. 71, Iss. 6, pp. 1313-1330
Open Access | Times Cited: 52
Histamine in cancer immunology and immunotherapy. Current status and new perspectives
María de la Paz Sarasola, Mónica A. Táquez Delgado, Melisa B. Nicoud, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 5
Open Access | Times Cited: 47
Light‐induced high‐efficient cellular production of immune functional extracellular vesicles
Shaobo Ruan, Nina Erwin, Mei He
Journal of Extracellular Vesicles (2022) Vol. 11, Iss. 3
Open Access | Times Cited: 33
The rising roles of exosomes in the tumor microenvironment reprogramming and cancer immunotherapy
Yu Wu, Wenyan Han, Hairong Dong, et al.
MedComm (2024) Vol. 5, Iss. 4
Open Access | Times Cited: 6
An insight into the risk factors of brain tumors and their therapeutic interventions
Sumbal Rasheed, Kanwal Rehman, Muhammad Sajid Hamid Akash
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112119-112119
Open Access | Times Cited: 37
Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect
Sara Nava, Daniela Lisini, Simona Frigerio, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12339-12339
Open Access | Times Cited: 37
Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4+ T cells through regulating type 2 conventional dendritic cells
Jing Luo, S.S. Pang, Zhenzhen Hui, et al.
Theranostics (2023) Vol. 13, Iss. 14, pp. 4836-4857
Open Access | Times Cited: 15
Immune landscape and response to oncolytic virus-based immunotherapy
Chaolong Lin, Wenzhong Teng, Tian Yang, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 3, pp. 411-429
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top